Lorcaserin 10mg

DRUG2 trials

Sponsors

Eisai Inc.

Conditions

ObesityRenal Impairment

Phase 1

Pharmacokinetic Properties of Lorcaserin in Subjects With Renal Impairment

CompletedNCT00828438

Eisai Inc.Renal Impairment

Start: 2008-10-31End: 2009-02-28Target: 40Updated: 2019-09-12

Pharmacokinetic Properties of Lorcaserin in the Fed and Fasted State

CompletedNCT00828724

Eisai Inc.Obesity

Start: 2008-11-30End: 2008-12-31Updated: 2019-09-12

Related Papers

Pharmacokinetics and Tolerability of Lorcaserin in Special Populations: Elderly Patients and Patients with Renal or Hepatic Impairment.

2017-03-307 citations